Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis
- 1 February 2019
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 122, e1557-e1561
Abstract
No abstract availableKeywords
Funding Information
- Varian Medical Systems
- National Institutes of Health (NIH P41EB015898)
This publication has 19 references indexed in Scilit:
- Immortal Time Bias: A Frequently Unrecognized Threat to Validity in the Evaluation of Postoperative RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guidelinePractical Radiation Oncology, 2012
- Epidemiology of Brain MetastasesCurrent Oncology Reports, 2011
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyJournal of Clinical Oncology, 2011
- Management of Single Brain Metastasis: A Practice GuidelineCurrent Oncology, 2007
- Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality CheckJournal of Clinical Oncology, 2007
- Brain metastases: epidemiology and pathophysiologyJournal of Neuro-Oncology, 2005
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004
- Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgeryAnnals of Neurology, 1993
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990